NIH grantwriting

National Institute Of Health 80858 1920

Summary of recent NIH Notices

NIH released several important notices over the last few weeks. Below is a brief summary of each item. To read each complete notice (NOT): https://grants.nih.gov/policy-and-compliance/notice-of-policy-changes Supporting Fairness and Originality in NIH Research Applications. NIH is evaluating applications closely for substantial use of AI. NIH also will now only accept a maximum of 6 applications per […]

Summary of recent NIH Notices Read More »

Signpost 3199323 1280

Spotlight on R34, R21, R61/R33: NIH Mechanisms to Help You Prepare for a Future R01-funded clinical trial

You have an idea for a full-scale clinical trial that you would like to eventually fund with an R01. How do you go from concept to R01 funding for the full-scale trial? NIH has several funding mechanisms that can help you lay the groundwork for a future R01-funded trial. Here, we outline some of the

Spotlight on R34, R21, R61/R33: NIH Mechanisms to Help You Prepare for a Future R01-funded clinical trial Read More »

Skyscraper 3122210 1920

A Comparison of 3 NIH New Innovator Awards (DP2): Office of the Director High-Risk, High-Reward; NIDA; and NIAID

The NIH DP2 activity code supports highly innovative research by new investigators in all areas of biomedical and behavioral research. NIH currently has three active DP2 Notices of Funding Opportunity (NOFO). We’ve summarized them for you below. It is always a good idea to speak with the program officers of these NOFOs to determine whether

A Comparison of 3 NIH New Innovator Awards (DP2): Office of the Director High-Risk, High-Reward; NIDA; and NIAID Read More »

Bouvier Grant Group logo white
Scroll to Top

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

Newsletter Popup